Stocks Health care CRVO
NASDAQ · Health careCervoMed Inc. (CRVO)
CervoMed Inc. brought in $331.3K of revenue over the twelve months to June 30, 2026, down 95.7% from a year earlier. It posted a net loss of $30.3M. At June 30, 2026 it held $22.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
Key facts about CervoMed Inc.
- Net worth
- CervoMed Inc. has a market value (market cap) of $21.2M at the latest share price, and shareholders' equity of $23M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $4M (-58.9% year on year), with a net loss of $27M. Over the 12 months to June 30, 2026: revenue $331.3K, net loss $30.3M.
- Cash flow
- In fiscal 2025 operations used $23.4M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 7, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- CervoMed Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
What CervoMed Inc. does
CervoMed Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CRVO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $4M | -$27M | -$2.98 | n/a |
| 2024 | $9.7M | -$16.3M | -$2.02 | n/a |
| 2023 | $7.1M | -$2.2M | -$0.82 | n/a |
| 2022 | $0 | -$5.8M | $2,038,891.00 | n/a |
| 2021 | n/a | -$24.1M | $1,946,859.00 | n/a |
| 2020 | n/a | -$14.2M | $1,073,509.70 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CRVO ranks in Health care
Latest SEC filings
What CervoMed Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 28, 2026
- September 10, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026
- August 7, 2026
- August 7, 2026
- August 4, 2026
Insider trades
What the people running CervoMed Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 11, 2026 | Boger Joshua SDirector, 10% owner | Boughtindirect | 955,414 | $3M |
| November 18, 2025 | Elder William RobertCFO, GC & Secretary | Bought | 2,500 | $20.8K |
| November 18, 2025 | Winton MatthewChief Commercial and Business | Bought | 1,500 | $11.9K |
| November 17, 2025 | Alam John JCEO & President, Director, 10% owner | Bought | 10,807 | $91.4K |
| November 17, 2025 | Alam John JCEO & President, Director, 10% owner | Boughtindirect | 10,793 | $91.3K |
| November 17, 2025 | Elder William RobertCFO, GC & Secretary | Bought | 1,000 | $8.5K |
| November 17, 2025 | Gregoire SylvieDirector, 10% owner | Bought | 10,793 | $91.3K |
| November 17, 2025 | Gregoire SylvieDirector, 10% owner | Boughtindirect | 10,807 | $91.4K |
Who owns CRVO
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Boger Joshua S13D, may seek influence | 20% | June 15, 2026 |
| Joshua S. Boger13D, may seek influence | 17.1% | February 28, 2024 |
| Armistice Capital, LLC13G, passive with 1 related filers | 9.53% | August 14, 2026 |
| RA Capital Management, L.P.13G, passive with 3 related filers | 8.6% | August 14, 2026 |
| Woodline Partners LP13G, passive | 5.1% | August 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 37 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Woodline Partners LP | 688,987 | new |
| Vanguard Capital Management LLC | 316,202 | 0 |
| Sabby Management, LLC | 248,880 | new |
| Geode Capital Management, LLC | 66,923 | -7,448 |
| BlackRock, Inc. | 53,845 | +2,185 |
| Byrne Asset Management LLC | 51,250 | +36,550 |
| Citizens Financial Group Inc | 37,477 | 0 |
| Vanguard Fiduciary Trust Co | 36,151 | 0 |
| Jane Street Group, LLC | 32,231 | +13,985 |
| Thompson Davis & CO., Inc. | 29,750 | +19,750 |
| Savvy Advisors, Inc. | 25,922 | 0 |
| State Street Corp | 20,527 | 0 |
| Cetera Investment Advisers | 19,622 | -7,715 |
| Summit Financial, LLC | 18,140 | new |
| Russell Investments Group, Ltd. | 15,363 | -727 |
| Northern Trust Corp | 13,318 | -16,726 |
| Morgan Stanley | 12,699 | -727,193 |
| HighTower Advisors, LLC | 11,919 | +654 |
| Fmr LLC | 10,538 | -502 |
| NFSG Corp | 3,000 | 0 |
Insiders
5 insiders reported holding 4,816,521 shares in total, about $6.7M at the last price.
| Holder | Shares |
|---|---|
| Boger Joshua SDirector, 10% owner | 1,795,8651,795,865 held indirectly |
| Alam John JCEO & President, Director, 10% owner | 1,496,57812,500 held indirectly |
| Gregoire SylvieDirector, 10% owner | 1,496,57812,500 held indirectly |
| Winton MatthewChief Commercial and Business | 15,000 |
| Elder William RobertCFO, GC & Secretary | 12,500 |
Questions about CRVO
What does CervoMed Inc. do?
CervoMed Inc. is a company in the Health care sector, listed on NASDAQ as CRVO. Its shares trade on NASDAQ under the ticker CRVO.
What is CervoMed Inc.'s net worth?
CervoMed Inc. has a market value (market cap) of $21.2M at the latest share price, and shareholders' equity of $23M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is CervoMed Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $30.3M on revenue of $331.3K.
How much revenue does CervoMed Inc. make?
Over the twelve months to June 30, 2026 CervoMed Inc. reported revenue of $331.3K. That is 95.7% less than a year earlier.
When did CervoMed Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 28, 2026.
When is CervoMed Inc.'s next earnings report?
CervoMed Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
Similar companies
Compare CRVO with
Follow CRVO
Get an email when CervoMed Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values CervoMed Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.